Gyre Therapeutics (GYRE) Assets Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.83% |
| Dec 31, 2025 | 32.48% |
| Sep 30, 2025 | 27.26% |
| Jun 30, 2025 | 26.23% |
| Mar 31, 2025 | 6.38% |
| Dec 31, 2024 | 7.61% |
| Sep 30, 2024 | 1,156.92% |
| Jun 30, 2024 | 875.71% |
| Mar 31, 2024 | 550.72% |
| Dec 31, 2023 | 37.50% |
| Sep 30, 2023 | -67.88% |
| Jun 30, 2023 | -85.13% |
| Mar 31, 2023 | -53.44% |
| Dec 31, 2022 | 52.26% |
| Sep 30, 2022 | -60.50% |
| Jun 30, 2022 | -18.09% |
| Mar 31, 2022 | -66.18% |
| Dec 31, 2021 | -41.31% |
| Sep 30, 2021 | -29.75% |
| Jun 30, 2021 | -17.70% |
| Mar 31, 2021 | 7.70% |
| Dec 31, 2020 | -3.76% |
| Sep 30, 2020 | 21.80% |
| Jun 30, 2020 | 22.61% |
| Mar 31, 2020 | -1.17% |
| Dec 31, 2019 | -21.11% |
| Sep 30, 2019 | -31.20% |
| Jun 30, 2019 | -27.71% |
| Mar 31, 2019 | -23.32% |
| Dec 31, 2018 | 216.15% |
| Sep 30, 2018 | 287.92% |
| Jun 30, 2018 | 252.11% |
| Mar 31, 2018 | 402.02% |
| Dec 31, 2017 | 3.74% |
| Sep 30, 2017 | -33.37% |
| Jun 30, 2017 | -30.74% |
| Mar 31, 2017 | -52.78% |
| Dec 31, 2016 | -45.21% |
| Sep 30, 2016 | -30.73% |
| Jun 30, 2016 | -43.44% |
| Mar 31, 2016 | -42.56% |
| Dec 31, 2015 | 2,232.14% |
| Sep 30, 2015 | -35.83% |
| Jun 30, 2015 | -18.75% |
| Mar 31, 2015 | -20.11% |
| Dec 31, 2014 | -97.96% |
| Sep 30, 2014 | -26.43% |
| Jun 30, 2014 | -25.66% |
| Mar 31, 2014 | -24.97% |
| Dec 31, 2013 | -23.05% |
| Sep 30, 2013 | -22.43% |
| Jun 30, 2013 | -21.23% |
| Mar 31, 2013 | -22.66% |
| Dec 31, 2012 | -26.56% |
| Sep 30, 2012 | -27.25% |
| Jun 30, 2012 | -29.13% |
| Dec 31, 2011 | -1.77% |